Concentrix (NASDAQ:CNXC) Hits New 1-Year Low Following Weak Earnings

Concentrix Corporation (NASDAQ:CNXC)’s stock price hit a new 52-week low on Tuesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $19.00 and last traded at $21.1980, with a volume of 202219 shares traded. The stock had previously closed at $25.23.

The company reported $2.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.64 by ($0.01). The firm had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.47 billion. Concentrix had a negative net margin of 13.35% and a positive return on equity of 17.80%. Concentrix’s revenue was up 1.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.70 EPS. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS.

Concentrix Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, August 4th. Stockholders of record on Friday, July 24th will be paid a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 6.9%. The ex-dividend date of this dividend is Friday, July 24th. Concentrix’s dividend payout ratio (DPR) is -6.68%.

Concentrix News Roundup

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Concentrix declared a quarterly dividend of $0.36 per share, implying a 5.7% annualized yield, which may support income-focused investors.
• Positive Sentiment: Management highlighted record quarterly cash flow from operations and adjusted free cash flow, along with strong growth in iX Suite deals and an AI push that could help margins over time.
• Neutral Sentiment: Robert W. Baird lowered its price target on CNXC from $40 to $30 while keeping an outperform rating, signaling caution but still modest upside from current levels. Benzinga
• Neutral Sentiment: Analysts and media coverage note that the stock is reacting to the company’s revised guidance and earnings details, while the broader market tone was mixed to slightly positive in pre-market trading. Reuters article
• Negative Sentiment: CNXC missed second-quarter EPS and revenue estimates, with revenue of about $2.46 billion and EPS of $2.63 falling just short of expectations.
• Negative Sentiment: The company cut FY2026 and Q3 guidance below Wall Street estimates, citing softer client spending and margin pressure, which is the main reason the stock is trading lower today.

Analysts Set New Price Targets

Several equities analysts recently weighed in on CNXC shares. Wall Street Zen lowered shares of Concentrix from a “buy” rating to a “hold” rating in a report on Saturday, March 28th. Weiss Ratings reissued a “sell (d)” rating on shares of Concentrix in a research note on Monday, April 27th. Barrington Research restated an “outperform” rating and issued a $38.00 price target on shares of Concentrix in a research report on Monday, June 22nd. Robert W. Baird dropped their price objective on Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday. Finally, Canaccord Genuity Group cut their target price on Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday, March 25th. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Concentrix has an average rating of “Moderate Buy” and an average price target of $41.00.

Insider Activity at Concentrix

In other news, CFO Andre S. Valentine purchased 2,500 shares of the firm’s stock in a transaction dated Thursday, April 9th. The stock was bought at an average price of $27.95 per share, with a total value of $69,875.00. Following the acquisition, the chief financial officer directly owned 89,066 shares of the company’s stock, valued at approximately $2,489,394.70. This represents a 2.89% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the company’s stock in a transaction on Wednesday, April 29th. The shares were sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the completion of the sale, the insider owned 2,773,667 shares of the company’s stock, valued at approximately $61,714,090.75. This represents a 68.39% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.90% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CNXC. Thompson Investment Management Inc. increased its stake in Concentrix by 36.9% during the 4th quarter. Thompson Investment Management Inc. now owns 216,154 shares of the company’s stock worth $8,988,000 after purchasing an additional 58,251 shares in the last quarter. Invenomic Capital Management LP lifted its stake in Concentrix by 19.7% in the third quarter. Invenomic Capital Management LP now owns 822,345 shares of the company’s stock valued at $37,951,000 after buying an additional 135,429 shares in the last quarter. Crossmark Global Holdings Inc. boosted its holdings in shares of Concentrix by 189.5% in the third quarter. Crossmark Global Holdings Inc. now owns 77,128 shares of the company’s stock valued at $3,559,000 after buying an additional 50,482 shares during the period. Hussman Strategic Advisors Inc. boosted its holdings in shares of Concentrix by 100.0% in the fourth quarter. Hussman Strategic Advisors Inc. now owns 84,000 shares of the company’s stock valued at $3,493,000 after buying an additional 42,000 shares during the period. Finally, Pzena Investment Management LLC increased its position in shares of Concentrix by 32.3% during the fourth quarter. Pzena Investment Management LLC now owns 2,927,196 shares of the company’s stock worth $121,713,000 after acquiring an additional 714,604 shares in the last quarter. 90.34% of the stock is owned by institutional investors and hedge funds.

Concentrix Price Performance

The company has a debt-to-equity ratio of 1.43, a current ratio of 1.18 and a quick ratio of 1.18. The company’s 50-day moving average price is $25.84 and its 200-day moving average price is $32.08. The company has a market cap of $1.27 billion, a P/E ratio of -0.97, a P/E/G ratio of 0.31 and a beta of 0.43.

About Concentrix

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.